AXQ Capital’s Treace Medical Concepts TMCI Stock Holding History

AXQ Capital’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-19,507	Closed	-$26.1K	–	1355
2026 Q1	$26.1K	Buy	19,507 +2,562	+15%	+$5.11K	﹤0.01%	956
2025 Q4	$41.5K	Buy	+16,945	New	+$73.6K	0.01%	694

Other funds holding TMCI

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

CBU

CIBC Bancorp USA Chicago, Illinois $82.3B AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

AXQ Capital's TMCI Position: Q2 2026 in Review

AXQ Capital sold out of Treace Medical Concepts (TMCI) in Q2 2026, closing a stake of 19,507 shares — an estimated $26.1K sold.

AXQ Capital first reported a position in TMCI in Q4 2025 and held it in 2 quarters. The position peaked at $41.5K in Q4 2025. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

AXQ Capital reported no remaining Treace Medical Concepts position as of Q2 2026 after selling out during the quarter.
AXQ Capital sold 19,507 Treace Medical Concepts shares in Q2 2026, an estimated $26.1K.
AXQ Capital first reported a position in Treace Medical Concepts in Q4 2025 and held it in 2 quarters.
AXQ Capital's Treace Medical Concepts position peaked at $41.5K in Q4 2025.
117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.